Genedrive plc
Company Profile
Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications.
The Company has assays on the market for the detection of MT-RNR1, HCV, certain military biological targets, a high throughput SARS-CoV-2 assay and a point of care test for Covid-19.
The company are currently developing a genetic test for CYP2C19 metaboliser status.
Latest Company Summary
Investor Access
The Company will be announcing its interim results for the six months ended 31 December 2023 on 28 March 2024.
The Company will provide a live presentation on Friday, 5 April 2024.
Investors can sign up to Investor Meet Company for free and add to meet genedrive plc: https://www.investormeetcompany.com/genedrive-plc/register-investorFriday 5 April 2024 at 10am
| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results | November |
| Interim Results* | March |
| AGM* | May |
* Months based on previous announcements of this kind
